Cadrenal Therapeutics, Inc. (CVKD)

NASDAQ: CVKD · IEX Real-Time Price · USD

0.429

+0.022 (5.33%)

At close: Apr 23, 2024, 2:55 PM

0.427

-0.003 (-0.58%)

After-hours: Apr 23, 2024, 4:00 PM EDT

Cadrenal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Market Capitalization	7	10	-
Enterprise Value	-2	1	1
PE Ratio	-1.15	-1.15	-
PB Ratio	0.85	1.25	-
P/FCF Ratio	-2.73	-2.73	-
P/OCF Ratio	-2.73	-2.73	-
EV/EBITDA Ratio	-0.15	-0.15	-0.09
EV/EBIT Ratio	-0.15	-0.15	-0.09
EV/FCF Ratio	-0.35	-0.35	-0.50
Debt / Equity Ratio	0.00	0.00	-0.12
Debt / EBITDA Ratio	0.00	0.00	-0.10
Debt / FCF Ratio	-0.01	-0.01	-0.53
Quick Ratio	10.16	10.16	0.02
Current Ratio	10.27	10.27	0.55
Interest Coverage	-487.69	-487.69	-61.68
Return on Equity (ROE)	-141.20%	-141.20%	-
Return on Assets (ROA)	-129.20%	-129.20%	-
Return on Capital (ROIC)	-98.95%	-98.95%	55.02%
Earnings Yield	-128.17%	-86.73%	-
FCF Yield	-54.19%	-36.67%	-
Buyback Yield / Dilution	-70.99%	-70.99%	-
Total Shareholder Return	-70.99%	-70.99%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).